By Sheeba M. | Weedstock Market Intelligence | October 7, 2026 — 7:00 PM ET
Wednesday's cannabis trading session closed with measured optimism as multistate operators held ground against broader market volatility, with selective strength in names tied to the IRS 280E reform narrative and Southeast adult-use expansion catalysts. Here's the full end-of-day breakdown and what investors should watch Thursday morning.
Wednesday Close: MSO Sector Summary
Curaleaf Holdings (CURLF) settled near session highs after absorbing early morning profit-taking pressure. With Florida adult-use legalization timelines firming up in the 2027 legislative cycle, Curaleaf's dominant retail footprint across the Southeast continues to attract institutional attention. Volume came in above the 30-day average, a constructive sign heading into Q3 earnings season.
Green Thumb Industries (GTBIF) saw a modest pullback into the close following Tuesday's outperformance, but remains in a technically healthy range above its 50-day moving average. The Illinois-heavy revenue mix positions GTBIF as a primary beneficiary of any federal 280E relief — a catalyst that remains the sector's most significant near-term trigger. Watch for any Federal Register updates overnight.
Verano Holdings (VRNOF) continued to consolidate after last week's breakout attempt, trading in a tight band. Management's focus on high-margin medical-to-recreational conversion markets keeps the long-term thesis intact. Any confirmation of favorable IRS guidance would disproportionately benefit operators like Verano running thin margins under the current tax burden.
The MSOS ETF ended the session slightly negative on the day but above the critical support level that defined Q3's recovery. Institutional flow data suggests positioning is building cautiously ahead of October's earnings calendar, with GTBIF and CURLF expected to report within the next six weeks.
After-Hours Developments to Monitor
After the close, cannabis trade publications flagged renewed Congressional activity around the SAFE Banking Act reintroduction timeline, with two Senate co-sponsors reportedly adding their signatures to a revised draft. While no floor vote is imminent, the incremental progress reinforces the legislative momentum narrative that has driven the sector's multi-week recovery from summer lows.
On the Canadian LP side, OGI (Organigram) and CGC (Canopy Growth) were quiet after hours, though German market developments — specifically BfArM's announcement of expanded pharmacy dispensary licenses — could move LP names with European exposure when Frankfurt opens Thursday morning.
Thursday October 8 Pre-Market Setup
Three catalysts to track before the Thursday open:
- DEA Federal Register: Any new rescheduling docket entries or comment period updates will be the primary sector mover. The October Federal Register cycle has been a consistent source of volatility for cannabis names.
- Weekly jobless claims (8:30 AM ET): Broader macro data will influence risk appetite. A softer print supports continued rotation into small/mid-cap cannabis names.
- Florida regulatory calendar: The Florida Department of Health is scheduled to publish updated MMTC license processing timelines — relevant for CURLF, TCNNF, and GTBIF Florida operations.
For a comprehensive view of how each of these catalysts maps to individual tickers, visit the Weedstock cannabis stock tracker for updated price targets and catalyst timelines.
The Forward View
The cannabis sector enters Thursday with the wind at its back — measured, not euphoric. The combination of 280E reform momentum, Florida adult-use expansion timelines, and a constructive macro backdrop creates a reasonable setup for continued accumulation in quality MSO names. The risk remains binary: a negative Federal Register development or earnings miss from a Tier 1 operator could unwind several weeks of progress quickly.
Disciplined positioning — overweight GTBIF and CURLF on fundamental conviction, with a watchful eye on VRNOF as a higher-beta leveraged play on 280E relief — continues to represent the most defensible approach heading into Q4.
Sheeba M. covers cannabis equity markets and regulatory developments for Weedstock. Nothing herein constitutes investment advice. Always conduct your own due diligence.
Track live prices and catalyst timelines: Weedstock Cannabis Stock Tracker →